Trichosporon beigelii, an emerging pathogen resistant to amphotericin B
about
Multidrug-resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care unitsDisseminated trichosporonosis caused by Trichosporon loubieriCurrent knowledge of Trichosporon spp. and TrichosporonosisPharmacokinetics and pharmacodynamics of antifungals in children: clinical implicationsInvasive Trichosporon Infection: a Systematic Review on a Re-emerging Fungal PathogenInvasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literatureIn vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungiEfficacy of LY303366 against amphotericin B-susceptible and -resistant Aspergillus fumigatus in a murine model of invasive aspergillosisIn Vitro Interactions between Non-Steroidal Anti-Inflammatory Drugs and Antifungal Agents against Planktonic and Biofilm Forms of Trichosporon asahiiNew and emerging yeast pathogensEvaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models.Clinical case of endocarditis due to Trichosporon inkin and antifungal susceptibility profile of the organism.Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.Efficacy, plasma pharmacokinetics, and safety of icofungipen, an inhibitor of Candida isoleucyl-tRNA synthetase, in treatment of experimental disseminated candidiasis in persistently neutropenic rabbits.PCR detection of DNA specific for Trichosporon species in serum of patients with disseminated trichosporonosis.In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole.Antifungal susceptibility testing: practical aspects and current challenges.In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatumSusceptibility patterns and molecular identification of Trichosporon speciesIn vitro antifungal susceptibilities of Trichosporon species.Testing conditions for determination of minimum fungicidal concentrations of new and established antifungal agents for Aspergillus spp.: NCCLS collaborative study.Antifungal agents: chemotherapeutic targets and immunologic strategies.Fungal infections: a growing threatTrichosporon loubieri infection in a patient with adult polycystic kidney disease.Trichosporon mycotoxinivorans, a novel respiratory pathogen in patients with cystic fibrosisActivities of D0870, a novel triazole, against Candida lusitaniae and Trichosporon beigelii in experimental murine infectionsEpidemiology of nosocomial fungal infections.Effects of granulocyte and granulocyte-macrophage colony-stimulating factors in a neutropenic murine model of trichosporonosis.Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis.Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.Emerging pan-resistance in Trichosporon species: a case report.Two Case Presentations Infected by Trichosporon asahii and Treated with Voriconazole Successfully.Epidemiology and Outcome of Trichosporon Fungemia: A Review of 185 Reported Cases From 1975 to 2014.Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome.A novel murine model of disseminated trichosporonosisFatal disseminated Trichosporon asahii infection in a child with acute lymphoblastic leukemiaDisseminated hyalohyphomycosis caused by a novel human pathogen, Fusarium napiformeGenetic diversity and antifungal susceptibility testing of Trichosporon asahii isolated of Intensive Care Units patientsRare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer.Antifungals: need to search for a new molecular target
P2860
Q24550785-FB799894-0D80-4BA4-8A36-31E4E818289EQ24649737-32BE801F-6BD8-4AA7-A9BA-D4D4595210B7Q26998573-F6A4F49E-39D2-4735-995E-0E5276AACBB8Q27025299-A9B7F592-C4D4-483A-9B38-198FE6A53042Q28071847-90B575E3-DE4C-4859-9FD7-2DDE4D70A0E4Q28243864-E4A75B57-9BA4-4231-8FB0-935FBFA5F300Q28355507-21067482-5734-4BED-9A5B-05D10DD1598DQ28379470-C2CBF8F2-6092-4594-8CAE-450FEA1EA5B7Q28550113-57ED8291-CAE4-4ADF-A6C8-8280A763C1D9Q30452880-4EF11A00-2C48-4F91-A07F-0767B01E52BBQ33689568-E60021D7-577E-4D47-80AA-084263966DEDQ33716130-F398B693-9133-4AF0-9252-580807549879Q33721804-1B6EA270-02BA-4D75-BC16-2411F7F808E0Q33770019-EC80EDE5-608B-4EBE-926C-D40C7A366049Q33959283-D438BA73-363C-4BFF-A8BF-3AB39DFB12C4Q33961573-9BAA262B-D6AE-4856-954C-3D137FDAAF23Q33975757-37BEDC85-7518-43A1-A954-0CF834463332Q33979873-0B4E6C76-8212-4F5E-A399-3CCB33EFA704Q34077156-EE205B4A-72F0-41CE-A898-6261DCC0A71EQ34106411-62694691-9F80-4727-9FAE-AD957338B667Q34195380-E0BD820D-A949-4942-A681-7DA343A35097Q34400044-9EF7814F-8A81-4D61-AD38-E1A78AB276E5Q34404601-B52926EB-0536-40C2-83EA-BB6EE8245D13Q34748873-F74E8B47-DAA9-4128-887B-B3EC94BF63FAQ34995831-16922A3A-08E5-4A1E-8555-6DA55F7FB9DBQ35112069-67CF508F-C3A1-46E7-9930-39A4A7B59DB0Q35372424-508677AB-4C4A-4E55-AD08-220AAD2E9D15Q35553643-C0E9644D-052C-40C0-BC68-7940D03D033BQ35822118-689E8F23-9A20-4918-A245-786861D58938Q35912243-0670166A-7478-42D6-811B-16920615F156Q35988869-8CAD5141-41F3-4FB9-B8EB-B73BA900888FQ35999226-83EDF040-720D-4F76-9F6E-7F2ED24DAA19Q36241645-D8C1B37C-7AA9-49E9-B4D1-AB52A6991AB3Q36528018-B6C28F34-8C2C-41B3-8C66-5077F1ED8D17Q36949656-1DBCBCDC-0F07-4A57-9E7B-ABADC23CABDFQ37021358-229A723A-6CEC-43F4-A446-4C2C0894D63EQ37128029-D1EC0AD3-4101-4DFA-B79B-EACAE2F35B95Q37159199-82308D27-AE57-41C2-8028-5F060AA60556Q37373824-3CD7ADEA-333E-41FA-9A0B-864810621FF3Q37666705-C3190B6A-3EB6-4B84-A62E-A3A62B25698C
P2860
Trichosporon beigelii, an emerging pathogen resistant to amphotericin B
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1990
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Trichosporon beigelii, an emerging pathogen resistant to amphotericin B
@en
Trichosporon beigelii, an emerging pathogen resistant to amphotericin B.
@nl
type
label
Trichosporon beigelii, an emerging pathogen resistant to amphotericin B
@en
Trichosporon beigelii, an emerging pathogen resistant to amphotericin B.
@nl
prefLabel
Trichosporon beigelii, an emerging pathogen resistant to amphotericin B
@en
Trichosporon beigelii, an emerging pathogen resistant to amphotericin B.
@nl
P2093
P2860
P1476
Trichosporon beigelii, an emerging pathogen resistant to amphotericin B
@en
P2093
Callender D
Lecciones J
McGough DA
Melcher GP
Rinaldi MG
P2860
P304
P407
P577
1990-07-01T00:00:00Z